Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q3 2014 · 10-Q
Revenue$530.60M$530.60M+5.0% vs Q3 2013 Net Income$11.50M$11.50MN/M vs Q3 2013 EPS Diluted$0.39$0.39N/M vs Q3 2013 Gross Profit$288,600,000+1.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
Operating Cash Flowderived$90,654,000+65.3% Free Cash Flowderived$63,299,000+83.5% Margins · derivedGross margin54.4%−1.9 pt vs Q3 2013
Operating margin6.3%+0.5 pt vs Q3 2013
Net margin2.2%+3.6 pt vs Q3 2013
ended Sep 30, 2014 · filed Nov 7, 2014 · 38 d after period end